drugset / Trial / NCT01857531

Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate

NCT01857531

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to evaluate whether the investigational drug ganaxolone can help smokers quit smoking. Ganaxolone is a drug that has been investigated (in other research studies) for the treatment of seizures and migraines. This drug is considered investigational in the US.

Timeline

Start
2013-06
Primary completion
2013-07
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ganaxolone Small molecule 1200 mg
Subject Nicotine Unknown 21 mg Topical

Indications

No indication recorded.